date:Dec 12, 2018
can barely make TMAO from dietary carnitine. The striking new finding about the pathway induced by ingesting carnitine, even if only provided as a supplement in a capsule form, provides important insights about new interventions to inhibit TMAO, which may help reduce risks for cardiovascular disease, says Dr. Hazen.
By uncovering this new pathway, we can potentially develop new treatments to interrupt this process before both the development and progression of cardiovascular disease, says Dr. H